Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation

J Dong, XD Cheng, WD Zhang… - Journal of Medicinal …, 2021 - ACS Publications
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that
regulates various biological processes, including proliferation, metastasis, angiogenesis …

Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update

J Dong, Z Qin, WD Zhang, G Cheng, AG Yehuda… - Drug Resistance …, 2020 - Elsevier
The presence of multidrug resistance (MDR) in malignant tumors is one of the primary
causes of treatment failure in cancer chemotherapy. The overexpression of the ATP binding …

Chalcone: A promising bioactive scaffold in medicinal chemistry

G Rajendran, D Bhanu, B Aruchamy, P Ramani… - Pharmaceuticals, 2022 - mdpi.com
Chalcones are a class of privileged scaffolds with high medicinal significance due to the
presence of an α, β-unsaturated ketone functionality. Numerous functional modifications of …

Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): an updated review

J Dong, L Yuan, C Hu, X Cheng, JJ Qin - Pharmacology & Therapeutics, 2023 - Elsevier
The emergence of multidrug resistance (MDR) in malignant tumors is one of the leading
threats encountered currently in many chemotherapeutic agents. The overexpression of the …

Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming …

S Wang, SQ Wang, QX Teng, ZN Lei… - Journal of Medicinal …, 2021 - ACS Publications
Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to
overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to …

Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3)

J Dong, J Yang, W Yu, H Li, M Cai, JL Xu… - Journal of Enzyme …, 2022 - Taylor & Francis
Gastric cancer remains a significant health burden worldwide. In continuation of our
previous study and development of effective small molecules against gastric cancer, a series …

Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors

J Dong, G Huang, Q Cui, Q Meng, S Li, J Cui - European journal of …, 2021 - Elsevier
Abstract Cytochrome P450 1B1 (CYP1B1) has been well validated as an attractive target for
cancer prevention and drug resistance reversal. In continuation of our interest in this area …

Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors

J Dong, Z Wang, J Cui, Q Meng, S Li - European journal of medicinal …, 2020 - Elsevier
Abstract Cytochrome P450 1B1 (CYP1B1) has been recognized as an important target for
cancer prevention and drug resistance reversal. In order to obtain potent and selective …

Excited state intramolecular proton transfer of 2-phenyl, 3-hydroxybenzo [g] quinolones in solution and in G4 supramolecular hydrogels

S Dutta, D Mandal - Journal of Molecular Liquids, 2022 - Elsevier
Abstract The 2-Phenyl, 3-Hydroxybenzo [g] quinolone (2P3HBQ) fluorophore and its
derivative, 2-(4′-hydroxyphenyl)-3-hydroxybenzo [g] quinolone (2HP3HBQ), exhibit well …

New perspectives of CYP1B1 inhibitors in the light of molecular studies

R Mikstacka, Z Dutkiewicz - Processes, 2021 - mdpi.com
Human cytochrome P450 1B1 (CYP1B1) is an extrahepatic heme-containing
monooxygenase. CYP1B1 contributes to the oxidative metabolism of xenobiotics, drugs, and …